PH12018501246A1 - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds - Google Patents
Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compoundsInfo
- Publication number
- PH12018501246A1 PH12018501246A1 PH12018501246A PH12018501246A PH12018501246A1 PH 12018501246 A1 PH12018501246 A1 PH 12018501246A1 PH 12018501246 A PH12018501246 A PH 12018501246A PH 12018501246 A PH12018501246 A PH 12018501246A PH 12018501246 A1 PH12018501246 A1 PH 12018501246A1
- Authority
- PH
- Philippines
- Prior art keywords
- solid forms
- phenylbenzo
- isoquinolin
- dihydro
- substituted
- Prior art date
Links
- 239000007787 solid Substances 0.000 title abstract 2
- IKLWZGVCUZDMEL-UHFFFAOYSA-N 6-phenyl-5,6-dihydrobenzo[f]isoquinolin-2-amine Chemical class C1=NC(N)=CC(C2=CC=CC=C22)=C1CC2C1=CC=CC=C1 IKLWZGVCUZDMEL-UHFFFAOYSA-N 0.000 title 1
- OLDWOVJAXRWCGT-FBHGDYMESA-N (6R)-6-(2-fluorophenyl)-N-[3-[2-(2-methoxyethylamino)ethyl]phenyl]-5,6-dihydrobenzo[h]quinazolin-2-amine dihydrochloride Chemical compound Cl.Cl.COCCNCCc1cccc(Nc2ncc3C[C@@H](c4ccccc4F)c4ccccc4-c3n2)c1 OLDWOVJAXRWCGT-FBHGDYMESA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562268747P | 2015-12-17 | 2015-12-17 | |
| PCT/US2016/067164 WO2017106642A1 (en) | 2015-12-17 | 2016-12-16 | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12018501246A1 true PH12018501246A1 (en) | 2019-02-04 |
Family
ID=59057612
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12018501246A PH12018501246A1 (en) | 2015-12-17 | 2018-06-13 | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
| PH12020551465A PH12020551465A1 (en) | 2015-12-17 | 2020-09-14 | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12020551465A PH12020551465A1 (en) | 2015-12-17 | 2020-09-14 | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US9981921B2 (enExample) |
| EP (2) | EP3390369B1 (enExample) |
| JP (2) | JP2018537499A (enExample) |
| KR (1) | KR20180086508A (enExample) |
| CN (1) | CN108368061A (enExample) |
| AU (2) | AU2016369523B2 (enExample) |
| BR (1) | BR112018012095A2 (enExample) |
| CA (1) | CA3006081A1 (enExample) |
| EA (2) | EA036295B1 (enExample) |
| ES (1) | ES2935818T3 (enExample) |
| HK (1) | HK1256825A1 (enExample) |
| IL (1) | IL259556B2 (enExample) |
| MX (2) | MX394320B (enExample) |
| NZ (1) | NZ742695A (enExample) |
| PH (2) | PH12018501246A1 (enExample) |
| SA (1) | SA518391805B1 (enExample) |
| SG (1) | SG11201804670PA (enExample) |
| TW (2) | TWI771280B (enExample) |
| WO (1) | WO2017106642A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017106639A1 (en) | 2015-12-17 | 2017-06-22 | Arqule, Inc. | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
| TWI771280B (zh) | 2015-12-17 | 2022-07-21 | 美商亞闊股份有限公司 | 經取代之5,6-二氫-6-苯基苯并[f]異喹啉-2-胺化合物之固體形式 |
| WO2022053708A1 (en) | 2020-09-14 | 2022-03-17 | Basilea Pharmaceutica International AG | Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma |
| JP7641247B2 (ja) | 2022-03-02 | 2025-03-06 | 日立建機株式会社 | 機械の性能診断装置 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| WO1998028281A1 (en) | 1996-12-23 | 1998-07-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| EP1638937B1 (en) * | 2003-06-18 | 2008-12-17 | Teva Pharmaceutical Industries Limited | Fluvastatin sodium crystal form xiv, processes for preparing it, compositions containing it and methods of using it |
| EP2079736B1 (en) * | 2006-12-29 | 2017-10-18 | Rigel Pharmaceuticals, Inc. | Substituted triazoles useful as axl inhibitors |
| MX2011006959A (es) * | 2008-12-30 | 2011-12-06 | Arqule Inc | Compuestos substituidos de 5,6-dihidro-6-fenilbenzo [f] isoquinolina-2-amina. |
| KR20130105675A (ko) * | 2010-11-25 | 2013-09-25 | 라티오팜 게엠베하 | 아파티닙의 신규 염 및 다형 |
| WO2012177852A1 (en) * | 2011-06-24 | 2012-12-27 | Arqule, Inc | Substituted imidazopyridinyl compounds |
| US9802954B2 (en) * | 2011-08-24 | 2017-10-31 | Boehringer Ingelheim International Gmbh | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma |
| EP2760859A1 (en) * | 2011-09-30 | 2014-08-06 | Sunshine Lake Pharma Co., Ltd | Crystalline forms of azilsartan and preparation and uses thereof |
| TWI771280B (zh) * | 2015-12-17 | 2022-07-21 | 美商亞闊股份有限公司 | 經取代之5,6-二氫-6-苯基苯并[f]異喹啉-2-胺化合物之固體形式 |
| WO2017106639A1 (en) * | 2015-12-17 | 2017-06-22 | Arqule, Inc. | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
| US9847831B2 (en) | 2016-04-08 | 2017-12-19 | Ciena Corporation | Dual wavelenth optical time domain reflectometer systems and methods embedded in a WDM system |
-
2016
- 2016-12-16 TW TW105141873A patent/TWI771280B/zh not_active IP Right Cessation
- 2016-12-16 CA CA3006081A patent/CA3006081A1/en active Pending
- 2016-12-16 HK HK18115910.5A patent/HK1256825A1/zh unknown
- 2016-12-16 EP EP16876769.7A patent/EP3390369B1/en active Active
- 2016-12-16 JP JP2018531388A patent/JP2018537499A/ja active Pending
- 2016-12-16 IL IL259556A patent/IL259556B2/en unknown
- 2016-12-16 EP EP21216052.7A patent/EP4019499A1/en active Pending
- 2016-12-16 WO PCT/US2016/067164 patent/WO2017106642A1/en not_active Ceased
- 2016-12-16 MX MX2021000432A patent/MX394320B/es unknown
- 2016-12-16 US US15/381,414 patent/US9981921B2/en active Active
- 2016-12-16 SG SG11201804670PA patent/SG11201804670PA/en unknown
- 2016-12-16 CN CN201680073181.8A patent/CN108368061A/zh active Pending
- 2016-12-16 EA EA201891430A patent/EA036295B1/ru unknown
- 2016-12-16 EA EA202091691A patent/EA202091691A1/ru unknown
- 2016-12-16 AU AU2016369523A patent/AU2016369523B2/en not_active Ceased
- 2016-12-16 KR KR1020187020340A patent/KR20180086508A/ko not_active Ceased
- 2016-12-16 MX MX2018007414A patent/MX385671B/es unknown
- 2016-12-16 ES ES16876769T patent/ES2935818T3/es active Active
- 2016-12-16 BR BR112018012095A patent/BR112018012095A2/pt not_active Application Discontinuation
- 2016-12-16 NZ NZ742695A patent/NZ742695A/en not_active IP Right Cessation
- 2016-12-16 TW TW111124239A patent/TWI796250B/zh active
-
2018
- 2018-04-30 US US15/966,091 patent/US10227311B2/en active Active
- 2018-06-13 SA SA518391805A patent/SA518391805B1/ar unknown
- 2018-06-13 PH PH12018501246A patent/PH12018501246A1/en unknown
-
2019
- 2019-01-30 US US16/261,744 patent/US10717710B2/en not_active Expired - Fee Related
-
2020
- 2020-09-14 PH PH12020551465A patent/PH12020551465A1/en unknown
-
2021
- 2021-11-26 JP JP2021191696A patent/JP2022031797A/ja active Pending
-
2022
- 2022-03-21 AU AU2022201947A patent/AU2022201947B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288104A (en) | Heterocyclic compounds, preparation methods and their use | |
| PH12017502090A1 (en) | Heterocyclic amides as kinase inhibitors | |
| EP3672973A4 (en) | HETEROCYCLIC COMPOUNDS USED AS KINASE INHIBITORS, COMPOSITIONS INCLUDING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF | |
| WO2017108723A3 (en) | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS | |
| PH12020551465A1 (en) | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds | |
| SG11202011513RA (en) | Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof | |
| PH12016502523A1 (en) | Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide | |
| MX2021015102A (es) | Inhibidores del receptor del factor estimulante de colonias 1 (csf-1r). | |
| TW201613886A (en) | 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones | |
| PH12015502041B1 (en) | Heteroaryl compounds and uses thereof | |
| PH12018500736A1 (en) | Methods for treating multiple sclerosis using pyrimidine and pyridine compounds with btk inhibitory activity | |
| MX2020011478A (es) | Formas solidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il) -1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmaceuticas y usos. | |
| GEP20186841B (en) | Stabilized crystal of tipiracil hydrochloride, and crystallization method for same | |
| IL271399A (en) | Methods for the preparation of heterocyclic 3,1-benzodioxole compounds | |
| EP3448852A4 (en) | NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF TYROSINE KINASE BCR-ABL | |
| MX2019011116A (es) | Inhibidores de la tirosina quinasa de bruton. | |
| IL271974A (en) | New intermediates useful for the synthesis of aminopyrimidine derivatives, a process for their preparation and a process for preparing aminopyrimidine derivatives using them | |
| DK3412673T3 (da) | Fremgangsmåde til fremstilling af pyrrolo[3,2-D]pyrimidin-forbindelse og mellemprodukter deraf | |
| MX2015013414A (es) | N-(2-ciano heterociclil)pirazolo piridonas como inhibidores de janus quinasa. | |
| ZA202401526B (en) | 2-homopiperazine-1-yl-4h-1,3-benzothiazine-4-one derivatives and process for the preparation of 2- (homo)piperazine 1,3-benzothiazine-4-one hydrochlorides | |
| MX2023001805A (es) | Formas solidas de 2-(5-(4-(2-morfolinoetoxi)fenil)piridin-2-il)-n- bencilacetamida. | |
| HK40113576A (zh) | 用於制备1，3-苯并二氧杂环戊烯杂环化合物的方法 | |
| HK40032669A (en) | Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate | |
| HK40037119A (en) | Pyrimidine compounds useful as tyrosine kinase inhibitors | |
| EP3727387A4 (en) | PYRIMIDINE COMPOUNDS USEFUL AS TYROSINE KINASE INHIBITORS |